Relevance of the American College of Surgeons Oncology Group Z0011 Trial to breast cancer in the Australian setting
Tóm tắt
Từ khóa
Tài liệu tham khảo
Giuliano, 2010, Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases, Ann. Surg., 252, 426, 10.1097/SLA.0b013e3181f08f32
Giuliano, 2011, Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial, JAMA, 305, 569, 10.1001/jama.2011.90
Gill, 2009, Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial, Ann. Surg. Oncol., 16, 266, 10.1245/s10434-008-0229-z
Mansel, 2006, Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial, J. Natl. Cancer Inst., 98, 599, 10.1093/jnci/djj158
Krag, 2010, Sentinel-lymph node resection compared with conventional axillary-lymph node dissection in clinically node-negative patients with breast cancer: overall survival findings from NSABP B-32 randomised phase 3 trial, Lancet Oncol., 11, 927, 10.1016/S1470-2045(10)70207-2
National Breast and Ovarian Cancer Centre Recommendations for use of sentinel node biopsy in early (operable) breast cancer 2010
Fant, 2003, Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection, Ann. Surg. Oncol., 10, 126, 10.1245/ASO.2003.04.022
Yi, 2010, Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database, Ann. Surg. Oncol., 17, S343, 10.1245/s10434-010-1253-3
Bilimoria, 2009, Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer, J. Clin. Oncol., 27, 2946, 10.1200/JCO.2008.19.5750
Hwang, 2007, Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection, Cancer, 110, 723, 10.1002/cncr.22847
Francissen, 2012, Axillary recurrence after a tumor-positive sentinel lymph node biopsy without axillary treatment: a review of the literature, Ann. Surg. Oncol., 19, 4140, 10.1245/s10434-012-2490-4
Guenther, 2003, Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes, Arch. Surg., 138, 52, 10.1001/archsurg.138.1.52
Jeruss, 2005, Axillary recurrence after sentinel node biopsy, Ann. Surg. Oncol., 12, 34, 10.1007/s10434-004-1164-2
Latosinsky, 2012, Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastases, Can. J. Surg., 55, 66, 10.1503/cjs.036011
Galimberti, 2013, Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial, Lancet Oncol., 14, 297, 10.1016/S1470-2045(13)70035-4
Park, 2007, A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram, Ann. Surg., 245, 462, 10.1097/01.sla.0000250439.86020.85
Pepels, 2012, Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells, Ann. Surg., 255, 116, 10.1097/SLA.0b013e31823dc616
De Boer, 2009, Micrometastases or isolated tumor cells and the outcome of breast cancer, N. Engl. J. Med., 361, 653, 10.1056/NEJMoa0904832
Caudle, 2011, Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial, Ann. Surg. Oncol., 18, 2407, 10.1245/s10434-011-1593-7
Ainsworth, 2012, The clinical impact of the American College of Surgeons Oncology Group z-0011 Trial- results from the BreastSurgANZ National Breast Cancer Audit, ANZ J. Surg., 82, 24
Naik, 2004, The risk of axillary relapse after sentinel node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures, Ann. Surg., 240, 462, 10.1097/01.sla.0000137130.23530.19